Fourth large-scale COVID-19 vaccine trial begins in the United States
Tom-Tom Traffic Data Of Top US Metros Suggests "Sluggish" Recovery
U.S. health agency sets October 16 deadline for states to submit vaccine plans
University of Cincinnati researchers to study the effects of razuprotafib on COVID-19 patients
How and when will we know that a COVID-19 vaccine is safe and effective?
Operation Warp Speed: Are Bad Vaccine Trial Outcomes Good?
CSU secures $3.1 million from NIH to advance SolaVAX coronavirus vaccine research
Fred Hutch-led clinical trial shows new smartphone app helps smokers quit
Carlyle Makes Strategic Growth Investment in TriNetX
SARS-CoV-2 infection can block pain, opening up unexpected new possibilities for research into pain relief medication
Coronavirus vaccine: why it's important to know what’s in the placebo
Explainer: How clinical trials test COVID-19 vaccines
T cell shortage linked to severe Covid-19 in elderly; antiseptic spray may limit virus spread
UM receives largest single research award in its history
Russia approves first Covid-19 prescription drug for sale in pharmacies
Moderna Publishes COVID-19 Vaccine Trial "Blueprint" To Quiet Concerns About Rushed Approval
Roche says a second trial of Actemra revives hopes for IL-6. What now?
Pfizer vaccine trial bets on early win against coronavirus, documents show
Jennifer Doudna sees CRISPR gene-editing tech as a Swiss Army knife for COVID-19 and beyond
Biden Joins FDA Critics, Seeks Independent Vaccine Review
University of Cincinnati research produces different results from key China COVID-19 study
NIH launches trial of Rigel drug for severe Covid-19
3 "Strong Buy" Healthcare Stocks With Major Catalysts Approaching
BioNTech Buys German Site From Novartis To Boost Covid-19 Vaccine Supply
Sorrento Pops 28% On FDA Nod To Kick Off Covid-19 Antibody Trial
AstraZeneca’s trial illnesses may not be due to Covid-19 shot, Oxford University says
China’s Sinovac to test coronavirus vaccine candidate in teenagers, children
Broad U.S. rollout of coronavirus vaccine could happen mid-2021: CDC
AstraZeneca’s trial illnesses may not be due to Covid-19 shot – Oxford University
Concerns Mount – FDA May Approve Deadly Vaccine